干细胞之家 - 中国干细胞行业门户第一站

 

 

搜索
朗日生物

免疫细胞治疗专区

欢迎关注干细胞微信公众号

  
查看: 399051|回复: 243
go

实时定量pcr [复制链接]

Rank: 1

积分
威望
0  
包包
8  
楼主
发表于 2012-5-17 17:06 |只看该作者 |倒序浏览 |打印
Real-time quantification of microRNAs by
) a6 S7 P' h0 \9 Qstem–loop RT–PCR+ T# K4 i% ^) I9 m! i$ J
Caifu Chen*, Dana A. Ridzon, Adam J. Broomer, Zhaohui Zhou, Danny H. Lee,
/ {% p$ J, @2 `Julie T. Nguyen, Maura Barbisin, Nan Lan Xu, Vikram R. Mahuvakar, Mark R. Andersen,$ z& N# Z7 n/ Q, `8 ~% J2 s7 B
Kai Qin Lao, Kenneth J. Livak and Karl J. Guegler. m+ x2 n: ~6 }; o" q+ H
Applied Biosystems, 850 Lincoln Centre Drive, Foster City, CA 94404, USA
+ F) B! _; k+ d0 [3 i0 Q3 ]  a+ eReceived May 24, 2005; Revised July 8, 2005; Accepted October 25, 2005
  @1 w3 c! T" W5 g! g  `ABSTRACT6 P8 p- _/ f9 L
A novel microRNA (miRNA) quantification method0 D0 T& ^' b5 t6 ^( \5 i0 i4 q+ [
has been developed using stem–loop RT followed4 i+ K, D% J2 x% Q8 R  n$ u& f
by TaqMan PCR analysis. Stem–loop RT primers are( J4 R1 p' K/ z7 t9 u
better than conventional ones in terms of RT efficiency) d4 e' R7 |7 j* N' S
and specificity. TaqMan miRNA assays are specific0 `. j0 s7 \7 V: Y3 e
for mature miRNAs and discriminate among
0 ]7 p- }7 l; irelated miRNAs that differ by as little as one nucleotide.1 @$ M# ^$ [# r& J
Furthermore, they are not affected by genomic1 O0 e6 k6 Z2 b% ^& L
DNA contamination. Precise quantification is
# n; ~7 E% t3 E4 j/ Z; p9 h- G" bachieved routinely with as little as 25 pg of total. \9 y% e3 b1 E& e
RNA for most miRNAs. In fact, the high sensitivity,7 i2 K) m& }( h
specificity and precision of this method allows for8 e% Z: o9 S; ?9 W# a
direct analysis of a single cell without nucleic acid
! b8 t' v3 _; [/ Qpurification. Like standard TaqMan gene expression
/ x5 D  m* O( s0 @  Lassays, TaqMan miRNA assays exhibit a dynamic
2 J* k" ]0 f: Z( K0 Y2 prange of seven orders of magnitude. Quantification5 S! ^2 J$ A& E) V# V
of five miRNAs in seven mouse tissues showed variation; L3 y) {: j4 w/ ]
from less than 10 to more than 30 000 copies per/ p$ o% ^0 E7 _9 c
cell. This method enables fast, accurate and sensitive
4 D8 M9 k+ k6 R6 ]' OmiRNA expression profiling and can identify and" u  g. p9 l$ t+ w# f# G% S+ b$ w% L
monitor potential biomarkers specific to tissues or7 D, T* l/ d$ _; w( n
diseases. Stem–loop RT–PCR can be used for the
% Z/ k6 I# ]& T8 L) Lquantification of other small RNA molecules such
/ u3 m- I% }3 C; L& ]as short interfering RNAs (siRNAs). Furthermore, the
! j  T: f/ e$ O1 E& e' |1 H& Bconcept of stem–loop RT primer design could be
7 @  v* H# |" `8 f& i% |5 b2 uapplied in small RNA cloning and multiplex assays
8 o4 h' J3 r/ F1 i8 jfor better specificity and efficiency." L5 B2 m, f" Y  h+ c& a! d9 {
INTRODUCTION
2 Q5 t4 g4 A6 J1 A5 R8 m! f3 {MicroRNAs (miRNAs) are naturally occurring, highly conserved
, W% c. X4 p( f3 v6 sfamilies of transcripts (18–25 nt in length) that are
0 e5 _0 o) l5 z. M* \processed from larger hairpin precursors (1,2). miRNAs are
  o% D5 T+ D) U% j4 mfound in the genomes of animals (3–9) and plants (10–12). To
7 Q- h% L( h7 A8 l* ydate, there are 1000 unique transcripts, including 326 human
6 _' g! X3 Y4 ymiRNAs in the Sanger Center miRNA registry (13).. L1 {5 i- \9 a. e
miRNAs regulate gene expression by catalyzing the cleavage
0 n  v9 D" r: b! cof messenger RNA (mRNA) (14–19) or repressing mRNA
6 s  t0 T! @- x3 stranslation (19–21). They are believed to be critical in cell
6 U! M* n* p$ mdevelopment, differentiation and communication (2). Specific8 [  W1 {* e5 R- w
roles include the regulation of cell proliferation and metabolism. O$ G9 k: D5 }% v  X% ^
(22), developmental timing (23,24), cell death (25),  L2 R- q7 a3 `
haematopoiesis (26), neuron development (27), human9 o! x. X9 z, `/ V" r4 U- A8 J- I
tumorigenesis (28) and DNA methylation and chromatin2 m5 G( h) N' f# @
modification (29).
5 A& i2 T. E; ^/ r- tAlthough miRNAs represent a relatively abundant class of7 \; O* I2 `0 F9 Q+ y& U9 B
transcripts, their expression levels vary greatly among species
0 ^$ u! i* A7 w8 r- o. z2 g3 Y7 eand tissues (30). Less abundant miRNAs routinely escape: x6 G# z1 @* x; i! U
detection with technologies such as cloning, northern hybridization
2 V/ `1 N8 s# w$ L. ?  b3 _  a(31) and microarray analysis (32,33). Here, we present' a$ W( ?* Q3 E
a novel real-time quantification method for accurate and sensitive
4 q; s) T, r7 x4 h! g. r$ x9 {6 Mdetection of miRNAs and other small RNAs. This method" _8 F6 \" |) P2 L9 K
expands the real-time PCR technology for detecting gene8 t0 B2 e) k" d( e/ A
expression changes from macromolecules (e.g. mRNAs) to
9 G" y6 b! ~8 j1 imicro molecules (e.g. miRNAs).& w7 ?! W5 L0 n8 o2 n( m
MATERIALS AND METHODS
$ d1 n6 c: j. X! T4 `Targets, primers and probes (Supplementary Data)/ S) X+ N( X% z2 B6 @3 r) E
Seventeen miRNA genes were selected from the Sanger: y) x$ G4 a; W
Center miRNA Registry at http://www.sanger.ac.uk/Software/$ ?" N& Q8 y+ u& ^
Rfam/mirna/index.shtml. All TaqMan miRNA assays are
; Y# _& F" E# T0 _6 _: F# s$ lavailable through Applied Biosystems (P/N: 4365409). Standard
$ S+ E  Q. ]4 n2 s0 A5 u# vTaqMan assays for pri-miRNA precursors, pri-let-7a-3
2 F7 [8 v) o# P+ l  Aand pri-miR-26b and pre-miRNA precursor pre-miR-30a were
5 {% L1 Y3 T/ j. H' w: ?0 jdesigned using PrimerExpress software (Applied Biosystems,$ r4 S8 ~" h3 N7 a2 l
Foster City, CA). All sequences are available in the
8 t( T# `0 g8 A+ W& k3 F8 A1 \section of the Supplementary Data. Synthetic miRNA oligonucleotides+ M. |. a- ?) h/ Z
were purchased from Integrated DNA Technologies3 p5 X7 [- d+ O8 ~% x! Z
Tissue RNA samples, cells, cell lysates and, i0 g. b4 x1 o3 x$ y
total RNA preparation: l  d* L2 y, B3 K/ _# M
Mouse total RNA samples from brain, heart, liver, lung,. x1 j9 M% Y; K' |
thymus, ovary and embryo at day 10–12 were purchased
2 ?- ^4 Q, f+ B: Ifrom Ambion (P/N: 7810, 7812, 7814, 7816, 7818, 7824,; a( Y! ]" a; t0 b* L% \
7826 and 7968). Ambion’s mouse total RNAs are derived
* \% t6 T# k7 g. Ifrom Swiss Webster mice. All RNA samples were normalized
4 g+ ^4 D/ x8 P: _- y$ {9 ~based on the TaqMan Gene Expression Assays for human or% ]4 E: y' j7 v+ \, C1 m
mouse glyceraldehyde-3-phosphate dehydrogenase (GAPDH)$ t4 }2 n0 ^- a9 U' @2 d7 |
endogenous controls (P/N: 4310884E and 4352339E, Applied
" A* b5 K7 |, \: Y/ T4 tBiosystems)." }% `; S! F! }/ B/ L) i
Two cell lines, HepG2 and OP9, were cultured using5 _* S7 E3 }4 Z0 y4 [. L2 b6 f
Gibco MEM (P/N: 12492–021, Invitrogen, Carlsbad, CA)# I$ k) f7 x( Z8 F( \
supplemented with 10% fetal bovine serum (FBS) (P/N:) g4 n$ N6 ?" r# E; g1 ~  Y- h( c! w$ F
SH30070.01, HyClone, Logan, UT). Trypsinized cells were
* g  k7 \3 ~6 n8 g# o0 bcounted with a hemocytometer. Approximately 2.8 · 106
( r; M: d/ t. R  c! isuspended cells were pelleted by centrifugation (Allegra 6,1 c2 }2 G8 A2 p; K- V
Beckman Coulter, Fullerton, CA) at 1500 r.p.m. for 5 min,5 E  }2 Z0 m: i% U9 ]! ^6 E0 T' L+ i& D
washed with 1 ml Dulbecco’s phosphate-buffered saline (PBS)
3 _3 X7 p" y1 L3 iwithout MgCl2 and CaCl2 (P/N: 14190078, Invitrogen, Carlsbad,
( _# P$ N8 r2 {$ h# ?* J* HCA). The cell pellets were re-suspended in 140 ml PBS2 \8 d' B7 x1 K* N0 _
and processed with three different sample preparation methods.0 u$ ?4 C, g9 j/ j
With the first method, a 50 ml sample (106 cells) was
" r& T  S7 X# C1 n7 ?- mmixed with an equal amount of Nucleic Acid Purification
- I& h1 V2 Z+ ]8 J, }Lysis Solution (P/N: 4305895; Applied Biosystems) by pipetting
- D- V" }; n5 b8 wup and down 10 times, and then spun briefly. The lysate
. x; K& S7 @' ~. i# Xwas diluted 1/10 with 1 U/ml RNase inhibitor solution (P/N:+ s* q" x8 ^/ D5 T' j
N8080119; Applied Biosystems) before adding the solution to/ p$ W* ~! R; t9 M) b: ~0 a2 i, h
an RT reaction. In the second method, a 50 ml sample (1068 B9 Z3 q, k" i/ }7 C5 V, _: {7 Z
cells) was used to purify total RNA using the mirVana
' U4 Q3 z+ d/ d6 L+ LmiRNA Isolation Kit (P/N: 1560, Ambion, Austin, TX)
2 E9 `! M; L# I4 l4 jaccording to the manufacturer’s protocol. Purified total
* _2 }. t+ @* J! G6 [$ sRNA was eluted in 100 ml of elution buffer. The third method
7 j  p" |8 M% n9 |$ k- l: Qinvolved diluting cells 1/2 with 1· PBS, heating at 95C for 5
1 n( \9 a- _# @- [3 wmin, and immediately chilling on ice before aliquotting directly
& k8 y1 I/ v2 l. ]+ X, uinto RT reactions.
  Q3 m' @4 k  B# YmiRNA detection using mirVana miRNA4 ~& l5 j$ a. K% w1 l
detection kit/ K1 O& _6 r0 T4 d9 ~; L0 k
Solution hybridization-based miRNA analysis was carried out
% l7 q2 q3 ^5 B* n, Eusing the mirVana miRNA Detection Kit (Cat. #: 1552,
4 n. v8 J+ {$ m, J0 xAmbion) according to the manufacturer’s protocol. RNA
2 j- q+ P" j* B% Fprobes were synthesized by IDT. The radioisotope labeled/ Z4 S# l+ m. o; w' x
RNA fragments were detected and quantitated with a Cyclone
6 j$ i- Y' f$ B$ Z& ^Storage Phosphor System (PerkinElmer, Boston, MA).; H: N# K* I$ W7 f* {+ T
Reverse transcriptase reactions
( h0 U, |  P& SReverse transcriptase reactions contained RNA samples
1 L6 Z6 w" s7 l+ w5 sincluding purified total RNA, cell lysate, or heat-treated0 h3 r) [: E6 W4 k) ?! `6 e
cells, 50 nM stem–loop RT primer (P/N: 4365386 and" n  E' b) O: E
4365387, Applied Biosystems), 1· RT buffer (P/N:
' t- U! r; ^9 k# _4319981, Applied Biosystems), 0.25 mM each of dNTPs,; @. T% M; {* j9 j
3.33 U/ml MultiScribe reverse transcriptase (P/N: 4319983,
7 r, u8 K! T* ?- ?" y( GApplied Biosystems) and 0.25 U/ml RNase inhibitor (P/N:& S' K) p. Z) ?) t7 K- B% H
N8080119; Applied Biosystems). The 7.5 ml reactions were& o- m0 V. I7 W$ E
incubated in an Applied Biosystems 9700 Thermocycler in a
, [: t; t; S0 H4 Q4 B96- or 384-well plate for 30 min at 16C, 30 min at 42C, 5 min
$ o  I8 Q% B! [, g. h+ \( Bat 85C and then held at 4C. All Reverse transcriptase reactions,
3 B, ^# K# h) ?including no-template controls and RT minus controls,
$ N$ q4 G9 u3 v; T& Vwere run in duplicate.
$ `8 q0 `: f2 J2 T0 y8 ~PCR7 W2 K# ^  ]. ^  x+ ~' T3 w2 n' Q
Real-time PCR was performed using a standard TaqMan- B) S8 U9 I- W0 r9 ~' t& @
PCR kit protocol on an Applied Biosystems 7900HT Sequence4 f0 b1 J' g6 C0 h, ?  a
Detection System (P/N: 4329002, Applied Biosystems). The
4 H7 X1 h0 b* D3 Y/ y  g10 ml PCR included 0.67 ml RT product, 1· TaqMan Universal
& r. _9 _- l8 x) ]5 \( a8 _- o5 @PCR Master Mix (P/N: 4324018, Applied Biosystems),
6 W3 V6 m& X5 z5 F" V0.2 mM TaqMan probe, 1.5 mM forward primer and 0.7 mM
2 y; S/ A& E# ?/ M) Dreverse primer. The reactions were incubated in a 384-well/ ~, u3 [, G/ @6 j% {
plate at 95C for 10 min, followed by 40 cycles of 95C for 15 s
! V3 d# U% w& pand 60C for 1 min. All reactions were run in triplicate. The
/ y' |( x9 S1 [& I0 wthreshold cycle (CT) is defined as the fractional cycle number
5 l7 E6 v4 R' ]9 uat which the fluorescence passes the fixed threshold. TaqMan
& [  s) W# H3 C* |$ kCT values were converted into absolute copy numbers using a
( Q& K1 [9 y- s, f) \& b' m: ustandard curve from synthetic lin-4 miRNA.: @: J6 K2 B9 j( _0 p
The method for real-time quantification of pri-miRNA4 G1 V) U* ]( e
precursors, let-7a-3 and miR-26b, and pre-miRNA precursor
% C. D& B+ E' I. c+ }% s/ p% QmiR-30a was described elsewhere (34).5 k/ r. J) H/ Y  G
RESULTS
! R' \( m2 Q# k. E; y5 ~% sWe proposed a new real-time RT–PCR scheme for miRNA
/ m* n8 j; ?* W$ O3 x2 m! a7 p, Rquantification (Figure 1). It included two steps: RT and realtime
% `* g3 I8 D, p- y1 p% T/ {PCR. First, the stem–loop RT primer is hybridized to a
  {/ v5 q+ Z6 nmiRNA molecule and then reverse transcribed with a Multi-3 M# f1 c! X' Y# p/ y4 j' M7 a
Scribe reverse transcriptase. Next, the RT products are quantified
" C5 _8 V, P/ F- _7 Xusing conventional TaqMan PCR.9 \$ E3 K% t) s, x$ p5 G
Figure 1. Schematic description of TaqMan miRNA assays, TaqMan-based' E. l& ^) w; v
real-time quantification of miRNAs includes two steps, stem–loop RT and realtime4 }& @0 o! @$ m, O; k& T) {) R
PCR. Stem–loop RT primers bind to at the 30 portion of miRNA molecules
0 e) J  w. B6 v2 K( Sand are reverse transcribed with reverse transcriptase. Then, the RT product is
% {7 E$ t* h% `0 g& Jquantified using conventional TaqMan PCR that includes miRNA-specific
" L+ a, V, b, k: e/ ^! i: jforward primer, reverse primer and a dye-labeled TaqMan probes. The purpose; P/ w' m  n& D" l4 r) Y
of tailed forward primer at 50 is to increase its melting temperature (Tm)  W* @5 `' s- C; y( @" S
depending on the sequence composition of miRNA molecules.The dynamic range and sensitivity of the miRNA quantification, R6 P/ H! N& K# L
scheme were first evaluated using a synthetic cel-lin-4
6 I* ~: {; ^9 L" dtarget. Synthetic RNA was quantified based on the A260 value
2 N! ?5 Y! `& }$ V4 Gand diluted over seven orders of magnitude. The cel-lin-4
+ K- F; N7 M* @TaqMan miRNA assay showed excellent linearity between0 c+ x' Z! N7 V9 h6 o5 m
the log of target input and CT value, demonstrating that the
8 ^) z4 p0 q2 k$ massay has a dynamic range of at least 7 logs and is capable of
+ v: n6 x* F6 C, Rdetecting as few as seven copies in the PCR reaction (Figure 2).- e. R/ D5 C0 e5 [/ s
Eight additional miRNA assays were also validated using6 v4 Q: |! _- h0 B' F4 K
mouse lung total RNA. The RNA input ranged from 0.025 to
" k8 y! |+ R9 F- J" a- L2 e250 ng (Figure 3). The CT values correlated to the RNA input& s/ }% J' c% f9 P. X
(R2 > 0.994) over four orders of magnitude. A negative control- `5 Z, l( \" ?( W( x) A
assay, cel-miR-2, did not give a detectable signal, even in
# ?' l/ w$ w, {+ p7 ureactions with 250 ng mouse total RNA.
* c& N) f  c' Z( JThe expression profile of five miRNAs was determined in8 G( }/ I7 j7 t3 \& A
seven different mouse tissues to create a miRNA expression5 }( H. s- M, L$ E. @9 ]  z" C
map. The copy number per cell was calculated based on the, V% {! {, v! r
input total RNA (assuming 15 pg/cell) and the standard curve
! H: U: L. y  B# {9 u* B3 Fof synthetic lin-4 target. Several interesting observations were
, Y" Q' I, \. ~7 o4 I7 f1 Smade from this expression map. First, miRNAs are very% R0 K1 A& q7 [" j
abundant, averaging 2390 copies per cell in these tissues.: L" `: D( P! f. |$ O/ {  t3 H3 ~& A2 p
The level of expression ranged from less than 10 to 32 090
; {6 F; C3 o; K) v+ h9 g& d4 lcopies per cell. Of the 12 miRNAs, miR-16 and miR-323 were! }( \1 E& o  B4 u2 t
the most and least abundant miRNAs, respectively, across all% d  U  \4 a- J) [6 D! z
tissues. In addition, each tissue had a distinctive signature of5 n3 W( g  M# [8 }% U, m, j
miRNA expression. The overall level of miRNA expression( {1 K) \4 f6 `' M: @, c
was highest in mouse lung and lowest in embryos. Finally, the6 g/ N$ T; {9 y3 j1 ]4 `2 v
dynamic range of miRNA expression varied greatly from less- `+ f1 W& m4 n6 v+ ^/ ^
than 5-fold (let-7a) to more than 2000-fold (miR-323) among  a3 e! L0 W& P- ]2 w4 d* O# N+ N
these seven tissues (Table 1).  M6 y! h4 A9 e5 x1 k6 e, y6 G- E& h3 f
To assess the need for RNA isolation, we added cell lysates
* |- M. d+ L. u9 }( Hdirectly to miRNA assays. The equivalent of 2.5–2500 cells
7 k! v% U7 R' b* Y+ qwere added directly to 7.5 ml RT reactions. When detected," W. s; [" \. B$ H7 k7 W' w  u
the CT values correlated (R2 > 0.998) to the number of cells inthe RT reactions over at least three orders of magnitude8 \& F7 j! V* l' G9 I
(Figure 4).9 T, T5 C0 J, ^0 Z. o* \' b
The effect of non-specific genomic DNA on TaqMan
* ~# k" B3 ]+ K. e* i5 Y6 dmiRNA assays was also tested for 12 assays. Results showed% A6 ~" A: j# X8 v8 d" z+ ?0 R& y8 Q! X
no difference in CT values in the presence or absence of 5 ng of4 {9 B5 ?$ B8 }1 ]2 m
human genomic DNA added to the RT reactions, suggesting
+ K; ]& |; d1 s5 Zthat the assays are highly specific for RNA targets (data not7 [& }, E( w* w" j" y
shown). Based on this observation, we added heat-treated cells2 R  @  ^  Z( \2 F3 s
directly to miRNA quantification assays. Figure 5 illustrates% M/ c) j  Z" g2 k% @( o
the comparison of miRNA quantification using purified totalRNA, cell lysates and heat-treated cells derived from an equal) k* @. v: u# U9 C
number of HepG2 cells. Adding heat-treated cells directly to0 _4 a% W: f- H4 c/ _
the miRNA assays produced the lowest CT values, and good
, p5 G* W. _+ h2 V2 B" E& kconcordance was observed among all three different sample. \3 B! \! e( j
preparation methods./ v; J' q" T+ U. s. D) Z
The reproducibility of TaqMan miRNA assays was
0 g& q5 I  X# P  I/ I1 _% C6 {examined by performing12 miRNA assays with 16 replicates1 U: `5 s2 j0 f: [# P( l
performed by two independent operators (data not shown).- Q2 ]( y; Q2 B9 `/ {: I
The standard deviation of the CTs averaged 0.1, demonstrating' ~: @$ i7 R5 [! c8 _, d
the high precision of the assays.
9 s( v7 t9 n3 l8 |6 c: ESolution hybridization-based miRNA northern analysis was
: X# K9 }  J8 [/ Vused as an independent technology to compare with TaqMan. A9 o" b9 t7 Q/ k% ]- m5 |
miRNA assays (Figure 6). We observed that hybridizationbased. R# i9 u3 W( z; p3 e9 }8 R" m
miRNA analyses were less reproducible and that concordance
5 U4 h1 x9 a, }$ d5 X: J1 T5 Qwith TaqMan assays varied from target to target.5 H/ i% p# }6 x# |( E; `
There was a general concordance between the two methods1 O# F) g. x( t; n7 e2 F) f  n
(R2 ¼ 0.916) for miR-16 across five mouse tissue samples.
; F' A+ f# s" {4 p% eHowever, correlations were relatively low for less abundant
7 g/ U3 J' I8 {7 `  B- WmiRNAs, such as miR-30 (R2 ¼ 0.751).4 z  w( z* b' T6 ?4 c
Hybridization methods can lack specificity for the mature- W/ [2 A, s0 J* p( d8 N7 \
miRNAs. We investigated the ability of the TaqMan miRNA. A' A0 C3 L3 p( {6 w. G/ _9 C
assays to differentiate between the mature miRNAs and their) D- g& z# q' U3 U  `. b
longer precursors, using synthetic targets for pri-miRNA precursors,
1 b3 `( Y# N3 U7 J  mpri-miR-26b and pri-let-7a and pre-miRNA precursor
; e6 g- S6 G! ~5 Dpre-miR-30a (Table 2). TaqMan assays designed to detect) i5 {3 s  F$ p( }  j1 i4 E
either precursors or mature miRNAs were tested with synthetic
& h0 R/ c  l" [8 J" btargets averaging 1.5 · 108 copies per RT reaction (1.3 · 107
6 j) L4 }, S- z: Q) B+ e2 q$ X% }) gcopies per PCR). TaqMan miRNA analyses with only primiRNA9 H; a% w& D' o1 X6 I' @6 d
precursor molecules produced CT values at least
8 M  ^+ a1 ~4 B  d9 a7 o11 cycles higher than analyses with mature miRNA ones.
9 D2 k# [) O+ x. Z1 l! ^This result implies that if mature miRNA and precursor
4 G) Z: F  O6 W% R. s( N3 K' `( Gwere at an equal concentration, the latter would contribute
0 E- P# @& ?# @) c: b5 k<0.05% background signal to the assay of mature target.
$ _0 v9 H, r( q, m2 K" _" c( ZFor pre-miR-30a where the mature miRNA miR-30a-3p is+ P8 E# a( N& ^; J* b
located at the 30 end of the pre-miR-30a sequence, a differenceof 8.4 CT was observed. The results showed that TaqMan
# Z0 P6 m* I7 ^1 R8 Y# KmiRNA assays are specific to mature miRNAs. However,7 J6 {4 M; q2 i3 ]* {3 r
the assay specificity is better if the miRNA is located at the" M( E1 \: _  ?
50 strand of the pre-miRNA precursor. Experiments analyzing  o6 P5 [3 F( _2 l
total RNA instead of synthetic targets indicated that the precursors" V* L' w( y* A
are at least two orders of magnitude less abundant than
; K" U: s; G/ A1 |1 `, rmature miRNAs, based on CT differences of 7 or more for
) p; R, w# l0 R7 [! N& y6 l% H. VmiR-26b-1 and let-7a-2 precursors. Considered together, these
/ S1 R" f" }  K% |: q6 @results suggest that the TaqMan miRNA assays are highly
6 {7 E' N9 E# j+ P0 M* Gspecific for the mature miRNAs.; k, X1 Q/ G/ m5 }9 x
The ability of the TaqMan miRNA assays to discriminate# g' H* t. f! g/ P: W4 C
miRNAs that differ by as little as a single nucleotide was tested
. y9 t( |. t# X8 ewith the five synthetic miRNAs of let-7a, let-7b, let-7c, let-7d
: Q9 M, s% \" S7 k/ jand let-7e (Figure 7). Each miRNA assay was examined
; B! C% F$ x6 M: magainst each miRNA. Relative detection efficiency was calculated" S4 U/ {+ w# c# u4 q
from CT differences between perfectly matched and3 b0 p' r/ R% K' }! l5 ^
mismatched targets, assuming 100% efficiency for the perfect
3 b2 k/ N, T1 c% vmatch. Very low levels of non-specific signal were observed,( Q# C: B+ p& @8 z, _1 _
ranging from zero to 0.3% for miRNAs with 2–3 mismatched
5 D9 {/ O( R1 k1 r  E; R* ?0 Kbases and only 0.1–3.7% for the miRNAs that differed by a5 i' L  F- k  z6 [! J
single nucleotide. Most cross-reactions resulted from G–T. U6 q( e9 Q; P4 `% i
mismatches during the RT reaction (let-7a assay versus let-
2 C4 q6 ~, {% @2 y& s; X7c target etc.). Only the targeted miRNA was detected if more
" Y/ Y) E5 G( M0 S  t8 Zthan three mismatched bases between any two miRNAs were" g1 b/ C! i) ^9 g
present.
$ ?. D9 c0 j0 ?4 r8 A7 u1 `We compared the discrimination ability of the TaqMan
* s/ k$ Z7 j; h3 D8 h- P6 Q9 jmiRNA assays to that of solution-based hybridization analysis- {* Q3 [5 q0 U4 q# S7 K% E, s
(Figure 8). In our hands, the hybridization method discriminated  P; N* Z$ X2 I8 y. ]6 D$ w$ j
well between let-7a and let-7b. However, poor or no
: r4 I9 ]* x3 wdiscrimination was observed among let-7a, let-7c and let-7 M- S3 q/ V  a% H- d
7d, which differ by 1–3 nt.
7 ~$ p" q9 ]8 S. R0 H/ K$ u( UWe speculated that stem–loop primers might provide better3 E& {  D+ U* C, B0 V. d  O
RT efficiency and specificity than linear ones. Base stacking of
8 i. G3 i+ ]3 d/ U* wthe stemmight enhance the thermal stability of the RNA–DNA8 L) o, i. b& Y  {
heteroduplex. Furthermore, spatial constraint of the stem–loop6 H9 M3 ?7 K$ n
would likely improve the assay specificity in comparison to- M5 W: @7 g5 U; t9 v
conventional linear RT primers. We compared the sensitivity. m6 Q) Z5 D: M5 F
and specificity of the stem–loop and linear RT primers using. Q$ ]6 G9 i; }9 i
synthetic miRNAs for let-7a (Figure 9). We observed several# D& m$ T* x. t6 r6 r, `
advantages for the stem–loop RT. First, in the presence of the
4 E8 I& F( ?1 Q# q0 Nsynthetic let-7a target, the CT values between linear and stem–- Q1 {" W- w! w
loop RT methods differed by 7, indicating that the efficiency of
( M* X. [! q3 ]" n( ?stem–loop RT was at least 100 times higher. Secondly, stem–" R, B* T: n! L1 p/ d2 v
loop RT discriminated better between miRNAs that differ by" o: {9 w# n& x
two bases based on DCT values. Finally, the stem–loop RT was
% {' B) ~; o3 Q* ], w1 F7 N, g; Oat least 100 times better able to discriminate between the1 v* }$ K. G( F
mature miRNA and its precursor, based on the DCT (precursor
! [# k: `3 V9 w* tversus mature) of 7.
- [% f' g& D$ I+ g  oDISCUSSION
" R' n; n* K0 bSince the discovery of miRNAs, remarkable advances in the; y, [- l5 V' \5 ~' r* p& c5 ?
characterization of these gene families have delineated the
1 ?% g5 J8 b# Lmechanism for their functions in gene regulation (35). As a
; ~1 g2 y  Q' g) J6 L8 m+ Aresult, extensive surveys have begun to identify miRNA biomarkers
- R" R* ~$ k2 s% B9 p# g( ]specific for tissue types or disease status. These studies
' t& `+ L2 _, b" |; nwill benefit from methods that allow for both accurate
" P) t* D. Y3 \( gidentification and quantification of miRNAs.7 d5 l7 q- S; D2 |
Current methods for detection and quantification of miRNAs
0 |6 Q+ I0 d# C+ `are largely based on cloning, northern blotting (5), or8 N  Y; l  W' u0 y& I5 O1 G
primer extension (36). Although microarrays could improve
! Z. ?, f& F0 I# E% rthe throughput of miRNA profiling, the method is relatively# q" V4 I2 `& _* S! Z
limited in terms of sensitivity and specificity (32,33). Low
, V( U) ]" o2 E. b0 bsensitivity becomes a problem for miRNA quantification
) d  ?; p! ]  Tbecause it is difficult to amplify these short RNA targets.
: W& u  q( Y# B4 FFurthermore, low specificity may lead to false positive signalfrom closely related miRNAs, precursors and genomic
+ d7 M, @$ U" `4 ^& d" isequences. More recently, a modified Invader assay has
& K' z* h, k0 d- ~& jbeen reported for the quantification of several miRNAs
" k- d, o4 W) ~( f% s(37). However, Invader assays have limited specificity and
8 L' e& v0 X/ J3 @7 n+ P+ ~+ w7 Wsensitivity, requiring at least 50 ng total RNA, or 1000$ F6 G: {( a: A, q
lysed cells, per assay.
/ O3 @) `$ P! _3 ~) u9 a8 wReal-time PCR is the gold standard for gene expression7 D+ s5 I. ]. M) P2 e- v/ `
quantification (38,39). It has been a long challenge for scientists
- a& \4 w, r0 f5 c8 K7 N! a9 c' Xto design a conventional PCR assay from miRNAs averaging
7 \. Y- F- x8 b) u1 b, @22 nt in length. We developed a novel scheme to0 N) l' }) f" c- P
design TaqMan PCR assays that specifically quantify
6 {6 f% @- ^- g# HmiRNA expression levels with superior performance over
( G: d: F8 r) Z+ I% a, Oexisting conventional detection methods. We have designed
, ~2 l% G/ B/ J7 _and validated assays for 222 human miRNAs (Chen et al.,7 z, w* O4 W- H# s# x/ F
unpublished data). These assays combine the power of PCR
7 \% F. E& Y0 ^- [for exquisite sensitivity, real-time monitoring for a large
3 y2 j8 [+ `3 hdynamic range and TaqMan assay reporters to increase the
+ d3 `' i- o% T9 o0 g7 q. Mspecificity. In our hands, miRNA precursors were at least 2000; ]& R: k/ O8 a1 P! g0 O; r2 e
times less effective targets than mature miRNAs (Table 2).$ @" l+ k/ ?3 W/ K
Because these assays are insensitive to precursors or genomic
7 s8 e8 w9 w' M) iDNA, we were able to add heat-treated cells directly to the" s! M8 l( K% i5 N. ~
assays, eliminating the need for sample preparation. For& ?0 i  k' b' K7 {
applications where both mature miRNAs and their precursors1 b/ Q, e$ E! v/ W6 M$ [
need to be assayed, conventional TaqMan assays can be used
& e8 Q% l5 ?  w2 ~/ Kin parallel to specifically detected precursors.
4 q6 L5 M- |1 [7 f: ]4 L2 D- ?- xWe observed the better specificity and sensitivity of stem–" z( M- V, M- l
loop RT primers than conventional linear ones likely due to the
2 j0 T9 ?3 O! y4 e+ r1 T: gbase stacking and spatial constraint of the stem–loop structure0 u2 R( S) g7 M3 a- U6 P
(Figure 9). The base stacking could improve the thermal stability
0 w) H8 n: V; T' c. M. ~and extend the effective footprint of RT primer/RNA
1 Y" ^7 ~, H/ p& f1 T$ Kduplex that may be required for effective RT from relatively( Z8 E! W+ ~$ }! Z: ]* {' w
shorter RT primers. The spatial constraint of the stem–loop: W* n1 c" x# h$ q: W2 R1 T3 }
structure may prevent it from binding double-strand genomic
  {/ D% F# I* C: N0 f4 t; P5 ]DNA molecules and, therefore, eliminate the need of TaqMan
9 w- R/ \, o8 jmiRNA assays for RNA sample preparation. Stem–loop
" j; q/ T# y/ Z6 j& a' NRT primers can potentially be used for multiplex RT reactions. W6 k! ~, m1 B4 y7 [
and small RNA cloning for possibly better efficiency and
+ A# ], C5 `+ Y. T. [7 t/ bspecificity.' s, k0 E2 u  h9 u
There is an increasing need for sensitive and specific whole
3 ~: a/ `% ?% }7 T8 lmiRNA profiling. The ability to effectively profile miRNAs1 y4 L: w7 f+ F7 a# n4 |/ h2 V* N
could lead to the discoveries of disease- or tissue-specific
! _" Z  Y( W7 [8 [! @" ^miRNA biomarkers, as well as contribute to the understanding
# l- n4 g) U7 s4 }of how miRNAs regulate stem cell differentiation. Our stem–
3 a" n0 L( A  iloop RT–PCR method should provide a practical solution for0 T0 ^% R4 f& p7 }4 p) y) \
these studies. We are currently developing multiplex: v" s, {' |' V( y) d/ a
approaches that should further increase the utility of this$ w: a2 q- X" `2 Y( V/ Q
method.

Rank: 2

积分
61 
威望
61  
包包
1757  
沙发
发表于 2015-5-26 21:10 |只看该作者
这个贴不错!!!!!  

Rank: 2

积分
116 
威望
116  
包包
1832  
藤椅
发表于 2015-6-4 17:10 |只看该作者
挺好啊  

Rank: 2

积分
122 
威望
122  
包包
1876  
板凳
发表于 2015-7-18 15:44 |只看该作者
干细胞之家微信公众号
一楼的位置好啊..  

Rank: 2

积分
104 
威望
104  
包包
1772  
报纸
发表于 2015-7-21 08:27 |只看该作者
支持你一下下。。  

Rank: 2

积分
61 
威望
61  
包包
1757  
地板
发表于 2015-8-8 19:24 |只看该作者
其实回帖算是一种没德德,所以我快成圣人了  

Rank: 2

积分
64 
威望
64  
包包
1782  
7
发表于 2015-8-29 13:42 |只看该作者
怎么就没人拜我为偶像那?? ~  

Rank: 2

积分
162 
威望
162  
包包
1746  
8
发表于 2015-8-29 16:01 |只看该作者
快毕业了 希望有个好工作 干细胞还是不错的方向

Rank: 2

积分
79 
威望
79  
包包
1769  
9
发表于 2015-9-12 19:01 |只看该作者
我喜欢这个贴子  

Rank: 2

积分
107 
威望
107  
包包
1889  
10
发表于 2015-9-28 20:55 |只看该作者
观看中  
‹ 上一主题|下一主题
你需要登录后才可以回帖 登录 | 注册
验证问答 换一个

Archiver|干细胞之家 ( 吉ICP备2021004615号-3 )

GMT+8, 2024-5-4 03:28

Powered by Discuz! X1.5

© 2001-2010 Comsenz Inc.